Trial Profile
A Phase IV Open Label Investigation of the Efficacy and Durability of Once Daily Antiretroviral Therapy With Kaletra [lopinavir/ritonavir] and Viread [tenofovir] in Antiretroviral Naive Patients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Therapeutic Use
- 19 Sep 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Jun 2008 New trial record.